Neurocrine Q2 Revenue Surges 39% to $959M; Soleno Acquisition Closed, $1B Credit Facility Secured
NBIX sits 54% above its 52-week low of $122.138.
Summary
Neurocrine Biosciences reported Q2 2026 revenue of $959M (+39% YoY) and net income of $144.4M, driven by strong product sales and the recent Soleno acquisition. The company also secured a $1B credit facility and continued share repurchases.
Key Events · Earnings and Guidance · NBIX
-
Q2 Revenue Hits $959M
Total revenues surged 39% year-over-year to $959.0 million, with INGREZZA at $716.5M, CRENESSITY at $183.5M, and newly acquired VYKAT XR contributing $54.3M.
-
Net Income More Than Doubles
Net income reached $144.4 million, or $1.39 per diluted share, compared to $107.5 million ($1.06) in Q2 2025, driven by revenue growth and a lower effective tax rate.
-
Soleno Acquisition Completed
The $2.9 billion acquisition of Soleno Therapeutics closed on May 18, 2026, adding VYKAT XR for Prader-Willi syndrome and expanding the rare disease portfolio.
-
$1B Credit Facility Secured
Entered into a five-year $1.0 billion senior secured revolving credit facility; no borrowings were outstanding as of June 30, 2026, providing significant financial flexibility.
Analysis · NBIX · Life Sciences
A standout quarter saw total revenues jump 39% year-over-year to $959 million, fueled by robust INGREZZA and CRENESSITY sales plus the addition of VYKAT XR from the newly closed Soleno acquisition. Net income more than doubled to $144.4 million, and the company secured a $1 billion revolving credit facility, providing ample liquidity. The period also featured continued share buybacks and the adoption of 10b5-1 trading plans by key executives. The only notable concern is a DOJ civil investigative demand regarding INGREZZA marketing practices, though the company is cooperating.
At the time of this filing, NBIX was trading at $188.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $18.7B. The 52-week trading range was $122.14 to $186.12. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.